AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (September 7, 2004). doi:10.1152/ajprenal.00051.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/F91    most recent
00051.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (34)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutton, T. A.
Right arrow Articles by Dagher, P. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutton, T. A.
Right arrow Articles by Dagher, P. C
Submitted on February 12, 2004
Accepted on August 30, 2004

Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury

Timothy A. Sutton1*, K. J Kelly1, Henry E Mang1, Zoya Plotkin1, Ruben M Sandoval1, and Pierre C Dagher1

1 Division of Nephrology, Department of Medicine and the Indiana Center for Biological Microscopy, Indiana University School of Medicine, Indianapolis, Indiana, USA

* To whom correspondence should be addressed. E-mail: tsutton2{at}iupui.edu.

Tetracyclines exhibit significant anti-inflammatory properties, inhibit matrix metalloproteinases (MMPs), and are protective in models of ischemia-reperfusion injury (IRI). Both inflammatory cascades and MMP activation have been demonstrated to modulate microvascular permeability. Because increased microvascular permeability occurs during IRI in a variety of organ systems including the kidney, we hypothesized that minocycline, a semisynthetic tetracycline, would diminish microvascular leakage during renal IRI. To test this hypothesis we utilized intravital 2-photon microscopy to examine leakage of fluorescent dextrans from the vasculature in a rodent model of IRI. Minocycline significantly reduced the extent of dextran (500 kDa) leakage from the renal microvasculature 24 hours after ischemia. Although minocycline diminished leukocyte accumulation in the kidney following ischemia, areas of leukocyte accumulation did not correlate with areas of microvascular permeability in either the saline or minocycline pretreated animals. Minocycline diminished the perivascular increase in MMP-2 and MMP-9, as well as, the increase in MMP-2 activity 24 hours after ischemia. ABT-518, a specific inhibitor of MMP-2 and MMP-9, also significantly reduced the extent of dextran (500 kDa) leakage from the renal microvasculature 24 hours after ischemia. Our results indicate that minocycline mitigates the renal microvascular permeability defect following IRI. This effect is spatially distinct from the effect of minocycline on leukocyte accumulation and may be related to diminished activity of MMPs on the integrity of the perivascular matrix.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. J. Jung, D. H. Kim, A. S. Lee, S. Lee, K. P. Kang, S. Y. Lee, K. Y. Jang, M. J. Sung, S. K. Park, and W. Kim
Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury
Am J Physiol Renal Physiol, October 1, 2009; 297(4): F952 - F960.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. J. Kelly, J. L. Burford, and J. H. Dominguez
Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy
Am J Physiol Renal Physiol, October 1, 2009; 297(4): F923 - F931.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. S. Machado, I. Y. Sazonova, A. Kozak, D. C. Wiley, A. B. El-Remessy, A. Ergul, D. C. Hess, J. L. Waller, and S. C. Fagan
Minocycline and Tissue-Type Plasminogen Activator for Stroke: Assessment of Interaction Potential
Stroke, September 1, 2009; 40(9): 3028 - 3033.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Jarvelainen, A. Sainio, M. Koulu, T. N. Wight, and R. Penttinen
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Pharmacol. Rev., June 1, 2009; 61(2): 198 - 223.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Bengatta, C. Arnould, E. Letavernier, M. Monge, H. M. de Preneuf, Z. Werb, P. Ronco, and B. Lelongt
MMP9 and SCF Protect from Apoptosis in Acute Kidney Injury
J. Am. Soc. Nephrol., April 1, 2009; 20(4): 787 - 797.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. A. Sharfuddin, R. M. Sandoval, D. T. Berg, G. E. McDougal, S. B. Campos, C. L. Phillips, B. E. Jones, A. Gupta, B. W. Grinnell, and B. A. Molitoris
Soluble Thrombomodulin Protects Ischemic Kidneys
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 524 - 534.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
C. Hudson, J. Hudson, M. Swaminathan, A. Shaw, M. Stafford-Smith, and U. D. Patel
Emerging Concepts in Acute Kidney Injury Following Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2008; 12(4): 320 - 330.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
D. Romero-Perez, E. Fricovsky, K. G. Yamasaki, M. Griffin, M. Barraza-Hidalgo, W. Dillmann, and F. Villarreal
Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection
J. Am. Coll. Cardiol., September 23, 2008; 52(13): 1086 - 1094.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. A. Reichel, M. Rehberg, P. Bihari, C. M. Moser, S. Linder, A. Khandoga, and F. Krombach
Gelatinases mediate neutrophil recruitment in vivo: evidence for stimulus specificity and a critical role in collagen IV remodeling
J. Leukoc. Biol., April 1, 2008; 83(4): 864 - 874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Horbelt, S.-Y. Lee, H. E. Mang, N. L. Knipe, Y. Sado, A. Kribben, and T. A. Sutton
Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F688 - F695.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Gupta, G. J. Rhodes, D. T. Berg, B. Gerlitz, B. A. Molitoris, and B. W. Grinnell
Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F245 - F254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Yu, R. M. Sandoval, and B. A. Molitoris
Rapid determination of renal filtration function using an optical ratiometric imaging approach
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1873 - F1880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Catania, G. Chen, and A. R. Parrish
Role of matrix metalloproteinases in renal pathophysiologies
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F905 - F911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. S. Awad, H. Ye, L. Huang, L. Li, F. W. Foss Jr., T. L. Macdonald, K. R. Lynch, and M. D. Okusa
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1516 - F1524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. M. Tiwari, R. W. Brock, J. K. Megyesi, G. P. Kaushal, and P. R. Mayeux
Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1324 - F1332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.